The Latest Cardiac and Vascular News
New editorial published in the Journal of the American College of Cardiology compares cardiovascular disease prevention treatments MANHASSET, N.Y.–(BUSINESS WIRE)–Patients most likely to benefit from intensive systolic blood pressure treatment (SBP) versus standard treatment to reduce cardiovascular disease (CVD) may also be at risk for adverse events (AE). In an […]
MORRISVILLE, N.C., April 28, 2021 /PRNewswire/ — A new peer-reviewed study accepted in the Journal of the American College of Cardiology: Cardiovascular Imaging validated Myocardial Solutions (“MSI”) technologies MyoStrain and MyoStress in a new stress testing protocol utilizing a hyperventilation breath-hold (HVBH) maneuver to accurately detect myocardial ischemia. The article demonstrated MyoStrain’s speed and sensitivity […]
Published Study Shows Combined Decrease in Heart Attacks and Strokes Among MDVIP Patients Relative to the General Population BOCA RATON, Fla., April 29, 2021 /PRNewswire/ — New research from MDVIP shows that its personalized and preventive approach to primary care helps reduce the incidence of cardiovascular events in at-risk patients. The study, […]
Cardiologists at Henry Ford Hospital Led the Development of Shock Treatment Protocol DETROIT, April 28, 2021 /PRNewswire/ — The results of a large, national heart attack study show that patients with a deadly complication known as cardiogenic shock survived at a significantly higher rate when treated with a protocol developed by cardiologists at […]
LJUBLJANA, Slovenia, April 29, 2021 /PRNewswire/ — MESI mTABLET ABI, device used for early detection of Peripheral Arterial Disease (PAD) by measuring Ankle-Brachial Index (ABI), has been announced as a finalist in the Cardiovascular Device category in the 2021 Medical Design Awards (MDEA) competition. MDEA is the premier awards program for the MedTech […]
Topline data expected in the second half of 2021 ST. GALLEN, Switzerland & UNIONDALE, NY–(BUSINESS WIRE)–Regulatory News: Vifor Pharma and Angion Biomedica Corp. (NASDAQ: ANGN), today announced completion of enrollment for Angion’s AKI-002-15 study, a phase-II trial of ANG-3777 in patients at risk of cardiac-surgery associated acute kidney injury (CSA-AKI). […]
DANVERS, Mass.–(BUSINESS WIRE)–The final results of the physician-led National Cardiogenic Shock Initiative (NCSI) Study demonstrate a 71% survival to discharge with greater than 90% native heart recovery when best practices are used, including placement of an Impella heart pump prior to revascularization (PCI). The study evaluated the outcomes of 406 consecutive patients who presented […]
DUBLIN, April 28, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced results from an interim analysis of the first 171 patients (including 71 roll-ins) treated in the OPTIMIZE PRO clinical study. The post-market, prospective, multi-center study is evaluating procedural outcomes (including pacemaker rate) associated with procedure-related […]
OXFORD, England, April 28, 2021 /PRNewswire/ — GEN inCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of cardiovascular disease, announces today a collaboration with Royal Brompton and Harefield hospitals (“RB&H”), recently merged with Guy’s and St Thomas’ NHS Foundation Trust (“GSTT”), to provide globally leading cardiovascular disease clinical genetic […]
Through ACC’s TRANSFORM program, three first-of-a-kind studies will apply implementation science to revolutionize care WASHINGTON, April 28, 2021 /PRNewswire/ — The American College of Cardiology (ACC) and HealthReveal, a leading clinical artificial intelligence company, are collaborating to employ HealthReveal’s personalized clinical AI solution to ACC’s TRANSFORM studies. Through the collaboration, study data […]
